AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 213 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $521,000 | -64.4% | 11,300 | -57.5% | 0.00% | -60.0% |
| Q2 2021 | $1,465,000 | +100.1% | 26,600 | +27.1% | 0.01% | +66.7% |
| Q3 2020 | $732,000 | +308.9% | 20,931 | +883.1% | 0.00% | +200.0% |
| Q2 2018 | $179,000 | -81.4% | 2,129 | -79.1% | 0.00% | -75.0% |
| Q1 2015 | $961,000 | -18.3% | 10,200 | -2.9% | 0.00% | -20.0% |
| Q4 2014 | $1,176,000 | -29.5% | 10,500 | -61.4% | 0.01% | +25.0% |
| Q3 2014 | $1,668,000 | – | 27,200 | – | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2013 | $67,000 | -23.0% | 2,800 | -9.7% | 0.00% | – |
| Q3 2013 | $87,000 | – | 3,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |